Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma

Mohammadi, Mohsen and Karimi Goudarzi, Peyman and Rahmani, Omid and Kaghazian, Peyman and Yahaghi, Emad and Taheriazam, Afshin and Ahmadi, Koroosh Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma. (ISOBM).

[img]
Preview
Text
821-1185-1-SM.pdf

Download (1MB) | Preview

Abstract

Abstract Current evidences have indicated that osteosarcoma is strongly associated with abnormal genetic and epigenetic changes that lead to the abnormal expression of oncogenes or methylation of tumor suppressor genes. In the present study, MACC1 and CDC5L mRNA levels in the patients with osteosarcoma were evaluated using quantitative real-time PCR. Our results demonstrated that CDC5L mRNA levels were higher in tumor tissues than in adjacent normal tissues (2.713 ± 0.738 vs. 1.071 ± 0.629; P < 0.05). Moreover, MACC1 was upregulated in tumor bone tissues than in adjacent normal tissues (3.221 ± 0. 624 vs. 1.427 ± 0.456; P < 0.05). Our result demonstrated that high expression of CDC5L was significantly related to advanced TNM stage (P = 0.032). No significant difference was determined between CDC5L mRNA expression and other clinicopathological parameters including age, gender, tumor diameter, location, tumor grade, and histological type. In addition, overexpression of MACC1 was strongly correlated with advanced TNM stage (P=0.027) and high tumor grade (P= 0.035). Our findings indicated that mRNA level of CDC5L is correlated with advanced TNM stage, and MACC1 may be involved in progression of osteosarcoma. Keywords Osteosarcoma . Expression . PCR . CDC5L . MACC1

Item Type: Article
Subjects: Q Science > Q Science (General)
Depositing User: sobhan rezaiian
Date Deposited: 21 Sep 2016 06:27
Last Modified: 21 Sep 2016 06:27
URI: http://eprints.lums.ac.ir/id/eprint/116

Actions (login required)

View Item View Item